SLIMMING COMPOUNDING PILLS - A POTENTIAL TRIGGER FOR LYELL SYNDROME

  • Ana Pedrosa Interna do Internato Complementar de Dermatologia e Venereologia/Resident, Dermatology and Venereology, Centro Hospitalar São João EPE, Porto, Portugal
  • Carmen Lisboa Assistente Hospitalar Graduada de Dermatologia e Venereologia/Graduated Consultant, Dermatology and Venereology Department, Centro Hospitalar São João EPE, Porto, Portugal Faculdade de Medicina da Universidade do Porto, Portugal/Faculty of Medicine, University of Porto, Portugal
  • Ana Paula Cunha Assistente Hospitalar Graduada de Dermatologia e Venereologia/Graduated Consultant, Dermatology and Venereology Department, Centro Hospitalar São João EPE, Porto, Portugal Faculdade de Medicina da Universidade do Porto, Portugal/Faculty of Medicine, University of Porto, Portugal
  • Joana Pardal 3Interna do Internato Complementar de Anatomia Patológica/Resident, Pathology Department, Centro Hospitalar São João EPE, Porto, Portugal
  • Filomena Azevedo Diretora do Serviço de Dermatologia e Venereologia/Head of the Dermatology and Venereology Department, Centro Hospitalar São João EPE, Porto, Portugal
Keywords: Anti-obesity agents/adverse effects, Epidermal necrolysis toxic

Abstract

The authors report the case of a 38-year-old woman with a history of depression medicated with fluoxetine and bromazepam for 2 years that presented a generalized and painful maculopapular rash evolving for 8 days and accompanied by fever. We found out she had been taking pills for weight loss handled in the pharmacy and started a new batch 3 weeks ago. The lesions progressed with mucosal involvement and formation of blisters and erosions covering an area of 40% of body surface, which together with the histopathology result allowed the diagnosis of Lyell syndrome. Under oral prednisolone 1.5mg/kg/day there was a complete resolution of the clinical manifestations in 15 days. We must highlight that slimming pills handled in pharmacies may become increasingly reported as triggers of Lyell syndrome. These tablets contain a miscellaneous of drugs, some understudied and with unknown pharmacokinetic interactions. Considering that these tablets are prepared in the pharmacy, we never know their exact composition or if they differ according to the batch.

Downloads

Download data is not yet available.
How to Cite
Pedrosa, A., Lisboa, C., Cunha, A. P., Pardal, J., & Azevedo, F. (1). SLIMMING COMPOUNDING PILLS - A POTENTIAL TRIGGER FOR LYELL SYNDROME. Journal of the Portuguese Society of Dermatology and Venereology, 72(1), 147-151. https://doi.org/10.29021/spdv.72.1.239
Section
Case Reports